cbdMD, Inc.
YCBD · AMEX
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $19,482 | $24,155 | $35,403 | $44,481 |
| % Growth | -19.3% | -31.8% | -20.4% | – |
| Cost of Goods Sold | $7,487 | $9,178 | $13,067 | $14,495 |
| Gross Profit | $11,996 | $14,978 | $22,337 | $29,986 |
| % Margin | 61.6% | 62% | 63.1% | 67.4% |
| R&D Expenses | $39 | $173 | $633 | $1,423 |
| G&A Expenses | $8,442 | $11,193 | $15,806 | $21,766 |
| SG&A Expenses | $12,623 | $18,143 | $31,250 | $39,339 |
| Sales & Mktg Exp. | $4,181 | $6,950 | $15,444 | $17,573 |
| Other Operating Expenses | $2,649 | $7,519 | $7,675 | $8,839 |
| Operating Expenses | $15,311 | $37,465 | $39,558 | $49,602 |
| Operating Income | -$3,190 | -$9,269 | $35,807 | -$19,616 |
| % Margin | -16.4% | -38.4% | 101.1% | -44.1% |
| Other Income/Exp. Net | -$511 | -$13,670 | -$52,773 | -$4,674 |
| Pre-Tax Income | -$3,700 | -$22,938 | -$70,084 | -$24,290 |
| Tax Expense | $0 | $0 | $0 | -$895 |
| Net Income | -$3,700 | -$22,938 | -$74,086 | -$23,395 |
| % Margin | -19% | -95% | -209.3% | -52.6% |
| EPS | -1.79 | -13.32 | -55.8 | -19.16 |
| % Growth | 86.6% | 76.1% | -191.2% | – |
| EPS Diluted | -1.79 | -13.32 | -55.8 | -19.16 |
| Weighted Avg Shares Out | 4,313 | 2,022 | 1,328 | 1,221 |
| Weighted Avg Shares Out Dil | 4,313 | 2,022 | 1,328 | 1,221 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $64 | $16 | $0 |
| Interest Expense | $30 | $0 | $0 | $29 |
| Depreciation & Amortization | $1,820 | $2,928 | $2,970 | $2,254 |
| EBITDA | -$1,495 | -$20,010 | -$15,477 | -$22,007 |
| % Margin | -7.7% | -82.8% | -43.7% | -49.5% |